You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

The Journal of Law,Medicine & Ethics

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Introduction

First published online 1992-9

Antiprogestin Drugs: Ethical,Legal and Medical Issues

and

Volume 20, Issue 3

https://doi.org/10.1111/j.1748-720X.1992.tb01181.x

Abstract

Get full access to this article

View all access options for this article.

References

1.

Glasier

A.

Thong

K.J.

Dewar

M.

, “Comparison of Mifepristone (RU 486) and High Dose Estrogen-Progestogen for Emergency Postcoital Contraception”, New England Journal of Medicine 1992, forthcoming.

2.

Grimes

D.A.

and Cook

R.J.

[editorial]“Mifepristone (RU 486): An Abortifacient to Prevent Induced Abortion?”

New England Journal of Medicine 1992, forthcoming.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Jonathan Mann's Legacy to the 21st Century: The Human Rights Imperative for Public Health

Retricted access

Infants with Trisomy 18 and Complex Congenital Heart Defects Should Not Undergo Open Heart Surgery

Retricted access

Health Insurance Exchanges: Legal Issues

Retricted access

Medicaid's Role for Children with Special Health Care Needs